Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)-Reference-Cited by-同舟云学术

Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Published:2013-03-28 Issue:9 Volume:98 Page:1467-1475
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Marcais A.,Porcher R.,Robin M.,Mohty M.,Michalet M.,Blaise D.,Tabrizi R.,Clement L.,Ceballos P.,Daguindau E.,Bilger K.,Dhedin N.,Lapusan S.,Bay J.-O.,Pautas C.,Garban F.,Ifrah N.,Guillerm G.,Contentin N.,Bourhis J.-H.,Agha I. Y.,Bernard M.,Cornillon J.,Milpied N.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan;Blood Advances;2024-02-13

2. Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source;Transplantation and Cellular Therapy;2023-04

3. Allogeneic Blood or Marrow Transplantation with Post-transplantation Cyclophosphamide for Peripheral T-cell Lymphoma: Importance of Graft Source;2022-09-01

4. Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes;Journal of Personalized Medicine;2022-01-18

5. Hodgkin Lymphoma and Non-Hodgkin Lymphoma;Blood and Marrow Transplant Handbook;2021